Cargando…

Understanding the Interactions between the Proteins Implicated in Legius Syndrome and Neurofibromatosis Type 1(♦): Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2016
Materias:	Molecular Bases of Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751361/ http://dx.doi.org/10.1074/jbc.P115.703710

Ejemplares similares

Legius Syndrome and its Relationship with Neurofibromatosis Type 1
por: DENAYER, Ellen, et al.
Publicado: (2020)

The SPRED1 Variants Repository for Legius Syndrome
por: Sumner, Kelli, et al.
Publicado: (2011)

Legius Syndrome: two novel mutations in the SPRED1 gene
por: Bianchi, Marika, et al.
Publicado: (2015)

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
por: Legius, Eric, et al.
Publicado: (2021)

Clinical and Genetic Findings in Children with Neurofibromatosis Type 1, Legius Syndrome, and Other Related Neurocutaneous Disorders
por: Giugliano, Teresa, et al.
Publicado: (2019)

Legius Syndrome in Fourteen Families
por: Denayer, Ellen, et al.
Publicado: (2011)

Legius syndrome: case report and review of literature
por: Benelli, Elisa, et al.
Publicado: (2015)

Structural Insights into the SPRED1-Neurofibromin-KRAS Complex and Disruption of SPRED1-Neurofibromin Interaction by Oncogenic EGFR
por: Yan, Wupeng, et al.
Publicado: (2020)

Lisch nodules and iris mammillations in two siblings with familial legius syndrome
por: Bixel, Kaitlyn D., et al.
Publicado: (2020)

Central precocious puberty in a girl with LEGIUS syndrome: an accidental association?
por: Orlandi, Valentina, et al.
Publicado: (2021)

Legius Syndrome and Inflammatory Bowel Disease: A Pediatric Case Report
por: Paixao, Filipa, et al.
Publicado: (2023)

RNF213 variant in a patient with Legius syndrome associated with moyamoya syndrome
por: Romanisio, Giulia, et al.
Publicado: (2021)

NMR resonance assignments of the EVH1 domain of neurofibromin’s recruitment factor Spred1
por: Führer, Sebastian, et al.
Publicado: (2017)

Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1
por: Chohan, Harleen, et al.
Publicado: (2018)

A Novel Frameshift Mutation in Neurofibromin 1 Gene in a Chinese Family with Neurofibromatosis Type 1
por: Dong, Ying-Ying, et al.
Publicado: (2017)

Moyamoya syndrome and neurofibromatosis type 1
por: Vargiami, Euthymia, et al.
Publicado: (2014)

Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
por: Santoro, Claudia, et al.
Publicado: (2018)

Neurofibromatosis type 1
por: Mançano, Alexandre Dias
Publicado: (2022)

RAS and beyond: the many faces of the neurofibromatosis type 1 protein
por: Anastasaki, Corina, et al.
Publicado: (2022)

Plexiform neurofibromatosis type 1
por: Sharma, Surendra K., et al.
Publicado: (2016)

Neurofibromatosis Type 1 in the Mandible
por: Uchiyama, Yuka, et al.
Publicado: (2018)

Hemostasis and Type 1 Neurofibromatosis
por: Niddam, Jeremy, et al.
Publicado: (2017)

Rare Association between Two Genetic Conditions: Turner Syndrome and Neurofibromatosis Type 1
por: El Qadiry, R., et al.
Publicado: (2022)

Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner
por: Alewine, Garrett, et al.
Publicado: (2022)

Cranio-orbital-temporal neurofibromatosis: An uncommon subtype of neurofibromatosis type-1
por: Acharya, Nibedita, et al.
Publicado: (2014)

Turner Syndrome and Neurofibromatosis 1: Rare Co-Existence with Important Clinical Implications
por: Mondal, Sunetra, et al.
Publicado: (2023)

Constitutional mismatch repair deficiency is the diagnosis in 0.41% of pathogenic NF1/SPRED1 variant negative children suspected of sporadic neurofibromatosis type 1
por: Perez-Valencia, Juan A., et al.
Publicado: (2020)

Statins, bone, and neurofibromatosis type 1
por: Korf, Bruce R
Publicado: (2008)

Neurofibromatosis Type 1 with Bladder Involvement
por: Üre, Iyimser, et al.
Publicado: (2013)

Zebrafish model of neurofibromatosis type 1
Publicado: (2012)

Becker's nevus with neurofibromatosis type 1
por: Kar, Sumit, et al.
Publicado: (2015)

Constipation in adults with neurofibromatosis type 1
por: Ejerskov, Cecilie, et al.
Publicado: (2017)

Brain tumors in neurofibromatosis type 1
por: Costa, Amanda De Andrade, et al.
Publicado: (2019)

Cutaneous Findings in Neurofibromatosis Type 1
por: Ozarslan, Bengisu, et al.
Publicado: (2021)

Bone Manifestations of Neurofibromatosis Type 1
por: Diallo, Ibrahima Dokal, et al.
Publicado: (2022)

Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient
por: Serafini, Natália Battisti, et al.
Publicado: (2017)

Endocrinological Evaluations of a Neurofibromatosis Type 1 Cohort: Is it Necessary to Evaluate Autoimmune Thyroiditis in Neurofibromatosis Type 1?
por: Güler, Serhat, et al.
Publicado: (2017)

Dermatofibrosarcoma Protuberans Presenting in a Patient With Neurofibromatosis Type 1: Potential Implications on Treatment
por: Eubanks, Bianca N, et al.
Publicado: (2021)

LIM Domain Kinases as Potential Therapeutic Targets for Neurofibromatosis Type 2
por: Petrilli, Alejandra, et al.
Publicado: (2013)

Zollinger-Ellison syndrome associated with neurofibromatosis type 1: a case report
por: Lee, Wan-Sik, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ees4d8ld9pg0na9mbef9vi1f4o